Extended‐release naltrexone for methamphetamine dependence among men who have sex with men: a randomized placebo‐controlled trial
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Background and aims: Methamphetamine use is increasingly prevalent and associated with HIV transmission. Early‐phase human studies suggested naltrexone reduced amphetamine use among dependent individuals. We tested if extended‐release naltrexone (XRNTX) reduces methamphetamine use and associated sexual risk behaviors among high‐risk methamphetamine‐dependent men who have sex with men (MSM). Design: Double‐blind, placebo‐controlled, randomized trial of XRTNX versus placebo over 12 weeks from 2012 to 2015. Setting: San Francisco Department of Public Health, California, USA. Participants: One hundred community‐recruited, sexually‐active, actively‐using methamphetamine‐dependent MSM. Mean age was 43.2 years; 96% were male, 3% transfemale, and 1% transmale; 55.0% were white, 19.0% African American, and 18.0% Latino. Interventions: XRNTX 380 mg (n = 50) or matched placebo (n = 50) administered by gluteal injection at 4‐week intervals. Measurements: Regression estimated average level and change in level of positive urines during the period 2–12 weeks (primary outcomes) and sexual risk behaviors (secondary outcome). Findings: Ninety per cent of visits were completed. By intent‐to‐treat, participants assigned to XRNTX had similar differences during 2–12 weeks in methamphetamine‐positive urines as participants assigned to placebo [incidence rate ratio (IRR) = 0.95, 95% confidence interval (CI) = 0.76–1.20; Bayes factor < 0.3]. Observed urine positivity declined from 78 to 70% in the XRNTX arm and 74 to 64% in the placebo arm. Adherence to injections was 96.7% in the XRNTX arm and 91.3% in the placebo arm. Sexual risk behaviors declined similarly among participants in both arms (all P > 0.05). There were no serious adverse events related to study drug and no differences in frequency of adverse events by treatment arm. Conclusions: Notwithstanding very high medication adherence for this study, extended‐release naltrexone does not appear to reduce methamphetamine use or sexual risk behaviors among methamphetamine‐dependent men who have sex with men compared with placebo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Motivational interviewing with problem drinkers
Miller, W. R. (1983) · Behavioural Psychotherapy · doi:10.1017/s0141347300006583 · Cited by 1,390
Internet Sex Addiction Treated With Naltrexone
Bostwick, J. M., & Bucci, J. A. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.2.226 · Cited by 265
Pharmacological approaches to methamphetamine dependence: a focused review
Karila, L., Weinstein, A., Aubin, H., Benyamina, A., Reynaud, M., & Batki, S. L. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03639.x · Cited by 242 · cited 1×
“There are no pharmacotherapies approved for treatment of methamphetamine use disorder [26,27].”
BackgroundSelf-citationFontenelle, L. F., Oostermeijer, S., Harrison, B. J., Pantelis, C., & Yücel, M. (2011) · Drugs · doi:10.2165/11591790-000000000-00000 · Cited by 234
Naltrexone for the Treatment of Amphetamine Dependence: A Randomized, Placebo-Controlled Trial
Jayaram-Lindström, N., Hammarberg, A., Beck, O., & Franck, J. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08020304 · Cited by 185 · cited 2×
“Furthermore, our participants were actively using methamphetamine, in contrast to an earlier trial of relapse prevention among amphetamine-dependent people [28].”
BackgroundResultMirtazapine to Reduce Methamphetamine Use: A Randomized Controlled Trial
Colfax, G. N. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.124 · Cited by 175 · cited 1×
“There are few exceptions to this trend, with mixed data for medications such as methylphenidate [63] and bupropion [64], and some early promise for mirtazapine, which is active in multiple neurotransmitter systems [65].”
BackgroundSelf-citationThe Economic Cost of Methamphetamine Use in the United States, 2005
Nicosia, N., Pacula, R., Kilmer, B., Lundberg, R., & Chiesa, J. (2009) · doi:10.7249/mg829 · Cited by 136
Augmentation with Naltrexone to Treat Compulsive Sexual Behavior: A Case Series
Raymond, N. C., Grant, J. E., & Coleman, E. (2010) · Annals of Clinical Psychiatry · doi:10.1177/104012371002200108 · Cited by 117
Heinzerling, K. G., Swanson, A., Hall, T. M., Yi, Y., Wu, Y., & Shoptaw, S. J. (2014) · Addiction · doi:10.1111/add.12636 · Cited by 64
Randomized controlled trial of a positive affect intervention for methamphetamine users
Carrico, A. W., Gόmez, W., Jain, J., Shoptaw, S., Discepola, M. V., Olem, D., Lagana-Jackson, J., Andrews, R., Neilands, T. B., Dilworth, S. E., et al. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.07.029 · Cited by 56
Cited by
Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review
Siefried, K. J., Acheson, L. S., Lintzeris, N., & Ezard, N. (2020) · CNS Drugs · doi:10.1007/s40263-020-00711-x · Cited by 194
Pharmacotherapy for methamphetamine/amphetamine use disorder—a systematic review and meta‐analysis
Chan, B., Freeman, M., Kondo, K., Ayers, C., Montgomery, J., Paynter, R., & Kansagara, D. (2019) · Addiction · doi:10.1111/add.14755 · Cited by 160
Randomized controlled trial of a positive affect intervention for methamphetamine users
Carrico, A. W., Gόmez, W., Jain, J., Shoptaw, S., Discepola, M. V., Olem, D., Lagana-Jackson, J., Andrews, R., Neilands, T. B., Dilworth, S. E., et al. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.07.029 · Cited by 56
Suspected nonfatal drug-related overdoses among youth in the US: 2016-2019
Roehler, D. R., Olsen, E. O., Mustaquim, D., & Vivolo-Kantor, A. M. (2021) · Pediatrics · doi:10.1542/peds.2020-003491 · Cited by 37
Hersi, M., Corace, K., Hamel, C., Esmaeilisaraji, L., Rice, D., Dryburgh, N., Skidmore, B., Garber, G., Porath, A., Willows, M., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0292745 · Cited by 13
Metadata
- Authors
- Coffin, P. O., Santos, G., Hern, J., Vittinghoff, E., Santos, D., Matheson, T., Colfax, G., & Batki, S. L.
- Venue
- Addiction
- Publisher
- Wiley
- Published
- 2017-08-29
- Volume
- 113
- Issue
- 2
- Pages
- 268-278
- ISSN
- 0965-2140 (ISSN-L)
- 1360-0443
- OpenAlex
- W2736602038
- Cited by
- 46
- References
- 12
- FWCI
- 3.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.